Suchergebnisse - "Patel, Sandip P"

PubPharm (68)

41

Management of Immunotherapy-Related Toxicities, Version 1.2019

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2019

von Thompson, J. | Schneider, B. | Brahmer, J. | +28

42

Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy : Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Malignancies

enthalten in: JCO precision oncology | 2019

von Kato, S. | Okamura, R. | Mareboina, M. | +11

43

Use of Low-Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non-Small-Cell Lung Cancer : A Multicenter Case Series

enthalten in: JCO precision oncology | 2018

von Jacobs, M. | Mohindra, N. | Shantzer, L. | +11

44

NCCN Guidelines Insights : Non-Small Cell Lung Cancer, Version 5.2018

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2018

von Ettinger, D. | Aisner, D. | Wood, D. | +30

45

Top Ten Tips for Palliative Care Clinicians Caring for Cancer Patients Receiving Immunotherapies

enthalten in: Journal of palliative medicine | 2018

von Wiesenthal, A. | Patel, S. | LeBlanc, T. | +2

46

Telomerase reverse transcriptase promoter alterations across cancer types as detected by next-generation sequencing : A clinical and molecular analysis of 423 patients

enthalten in: Cancer | 2018

von Schwaederle, M. | Krishnamurthy, N. | Daniels, G. | +7

47

Path toward Precision Oncology : Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management Support

enthalten in: Molecular cancer therapeutics | 2017

von Chae, Y. | Pan, A. | Davis, A. | +4

CommentIn: Mol Cancer Ther. 2017 Dec;16(12):2641-2644. - PMID 29203693

48

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

enthalten in: Molecular cancer therapeutics | 2017

von Goodman, A. | Kato, S. | Bazhenova, L. | +6

49

Hypermutated Circulating Tumor DNA : Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2017

von Khagi, Y. | Goodman, A. | Daniels, G. | +5

50

Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2017

von Schwaederlé, M. | Patel, S. | Husain, H. | +6